• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

Share:

September 23, 2020

Highlights on this story:
  • XRHealth has just received a patent for its approach to incorporate biofeedback from devices such as an Apple watch into its remote healthcare therapy platform that utilizes virtual/artificial reality (VR/AR).
  • XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical-grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat.

XRHealth, the leader in extended reality therapeutic applications, announces that they received a patent to utilize approaches that incorporate biofeedback into their extended reality therapy. U.S. Patent No. 16/067,480, entitled “A Therapy and Physical Training Device,” was issued on September 15, 2020.

These novel approaches enable VR/AR therapy to address patient pain based on biofeedback such us heart rate variability, EEG, galvanic skin response, and other critical responses while patients are using the VR/AR devices. Solutions that incorporate biofeedback allow patient treatment to be customized according to their unique needs and better inform clinicians on how patients are responding to therapy.

VR/AR therapy Integration with Apple Watch

XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat. XRHealth will use the output measurements of the Apple Watch to detect pain, which will modify VR/AR therapy treatment for patients based on the pain that they feel during the sessions.

“The newly awarded patent reflects XRHealth’s commitment to creating the most sophisticated form of therapy that responds to patient physical needs in real-time,” said Eran Orr, CEO of XRHealth. “Virtual Reality therapy that incorporates biofeedback will enhance and personalize the patient experience and provide clinicians with critical insights.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

XRHealth created the first virtual reality telehealth clinic in the world that treats multiple conditions like anxiety & stress, cognitive impairment, pain management, Parkinson’s, and multiple sclerosis. XRHealth provides doctors with patient data that allows them to monitor and treat them in real-time.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Valet Health & DataBiologics Combined Solution Support of Data-Driven Physicians Offering Orthobiologics TreatmentsValet Health & DataBiologics Combined Solution Support of Data-Driven Physicians Offering Orthobiologics Treatments
  • Takeda shopping Western Europe drug portfolioTakeda shopping Western Europe drug portfolio
  • Evidation Health and HHS to Develop Predictive Algorithm for COVID-19 DetectionEvidation Health and HHS to Develop Predictive Algorithm for COVID-19 Detection
  • Alexion to obtain SyntimmuneAlexion to obtain Syntimmune
  • Resolian Acquires China-Based Bioanalytical CRO Denali MedpharmaResolian Acquires China-Based Bioanalytical CRO Denali Medpharma
  • Highmark BCBS Expands Access to Freespira’s Digital Therapeutic to Help Treat PTSD, Panic AttacksHighmark BCBS Expands Access to Freespira’s Digital Therapeutic to Help Treat PTSD, Panic Attacks
  • Life Science Software Market | Global Trends, Growth, Size, Future Demands, Segmentation, Sales Revenue, Latest InnovationLife Science Software Market | Global Trends, Growth, Size, Future Demands, Segmentation, Sales Revenue, Latest Innovation
  • Camargo Pharmaceutical Services Enhances Drug Development Services Through Acquisition of Montreal-based InSymbiosisCamargo Pharmaceutical Services Enhances Drug Development Services Through Acquisition of Montreal-based InSymbiosis

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications